Drug firm urged to lift US block on abortion pill

A DRUG and chemicals company which has blocked the introduction of the abortion pill RU486 in the US because it fears a boycott of its other products, is under increasing international pressure to make it available there.

Leading family planning and 'pro-choice' groups in the UK, France and Germany are lending support to demands that Hoechst, a major shareholder in Roussel, which makes RU486, withdraws its opposition to the sale of the drug in the US immediately. They believe that US approval will pave the way for safe, non-surgical abortions for women world-wide.

Professor Etienne Baulieu, the inventor of the drug, told a conference in Frankfurt, Germany, at the weekend that Hoechst was also under pressure from other drug companies which are asking to buy the rights to supply RU486 in the US.

Hoechst has opposed a product licence application for RU486 on the grounds that the US political climate was not right. There have been threats of a boycott of Hoechst products, which include plastics, dyes and agro-chemicals, by 'pro-life' activists. Similar threats led to a withdrawal of RU486 for a time in France. The drug was reintroduced there in January 1989 after the French government said it would pass the patent rights to another company unless it was reinstated.

Women's rights activists, 'pro- choice' groups and some doctors say that the political climate in America has changed and that thousands of women are being denied the drug because of the company's intransigence. They point out that Bill Clinton, the president-elect, has indicated his support for RU486.

Professor Baulieu said: 'Hoechst has the right not to develop a product which doesn't fit in with what it sees as its medical mission. But if they don't use it when it has been shown to be safe and useful, there is a moral obligation on them to license it to someone else.'

Professor Baulieu said US acceptance would mean speedy approval for RU486 in many other countries, including Germany.

Dr Halfdan Mahler, secretary general of the International Planned Parenthood Federation, told the conference: 'Since they are so embarrassed by holding the patent for RU486, why don't they give it away.' A non-profit organisation would be a suitable candidate, 'otherwise women in developing countries will have to wait for decades'.

Professor Wolfgang Hilger, chairman of Hoechst, will today receive an open letter from RU486 supporters in the UK, Europe and the US, who attended the conference. They express 'grave concern with Hoechst's stubborn refusal to apply for a product licence for RU486 in those countries in which abortion is lawful'.

British signatories include the Birth Control Trust and the Pro Choice Alliance. Both Hoechst and Roussel were unavailable for comment yesterday.

RU486 works by blocking the hormone progesterone which is needed to maintain pregnancy. The drug was introduced here in July 1991, but so far it has been taken by fewer than 3,000 women, which is thousands less than was expected, according to the Birth Control Trust.

The trust blames widespread ignorance among family doctors of the drug's availability and the reluctance of NHS hospitals to adapt their gynaecological units for its use.

Leading article, page 14

Start your day with The Independent, sign up for daily news emails
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Ashdown Group: Practice Accountant - Bournemouth - £38,000

£32000 - £38000 per annum: Ashdown Group: A successful accountancy practice in...

SThree: Trainee Recruitment Consultant

£18000 - £23000 per annum + Uncapped commission: SThree: Does earning a 6 figu...

Recruitment Genius: SEO Executive

£18000 - £25000 per annum: Recruitment Genius: This is an exciting opportunity...

Recruitment Genius: New Lift Sales Executive - Lift and Elevators

£35000 - £40000 per annum: Recruitment Genius: A challenging opportunity for a...

Day In a Page

The saffron censorship that governs India: Why national pride and religious sentiment trump freedom of expression

The saffron censorship that governs India

Zareer Masani reveals why national pride and religious sentiment trump freedom of expression
Prince Charles' 'black spider' letters to be published 'within weeks'

Prince Charles' 'black spider' letters to be published 'within weeks'

Supreme Court rules Dominic Grieve's ministerial veto was invalid
Distressed Zayn Malik fans are cutting themselves - how did fandom get so dark?

How did fandom get so dark?

Grief over Zayn Malik's exit from One Direction seemed amusing until stories of mass 'cutting' emerged. Experts tell Gillian Orr the distress is real, and the girls need support
The galaxy collisions that shed light on unseen parallel Universe

The cosmic collisions that have shed light on unseen parallel Universe

Dark matter study gives scientists insight into mystery of space
The Swedes are adding a gender-neutral pronoun to their dictionary

Swedes introduce gender-neutral pronoun

Why, asks Simon Usborne, must English still struggle awkwardly with the likes of 's/he' and 'they'?
Disney's mega money-making formula: 'Human' remakes of cartoon classics are part of a lucrative, long-term creative plan

Disney's mega money-making formula

'Human' remakes of cartoon classics are part of a lucrative, long-term creative plan
Lobster has gone mainstream with supermarket bargains for £10 or less - but is it any good?

Lobster has gone mainstream

Anthea Gerrie, raised on meaty specimens from the waters around Maine, reveals how to cook up an affordable feast
Easter 2015: 14 best decorations

14 best Easter decorations

Get into the Easter spirit with our pick of accessories, ornaments and tableware
Paul Scholes column: Gareth Bale would be a perfect fit at Manchester United and could turn them into serious title contenders next season

Paul Scholes column

Gareth Bale would be a perfect fit at Manchester United and could turn them into serious title contenders next season
Inside the Kansas greenhouses where Monsanto is 'playing God' with the future of the planet

The future of GM

The greenhouses where Monsanto 'plays God' with the future of the planet
Britain's mild winters could be numbered: why global warming is leaving UK chillier

Britain's mild winters could be numbered

Gulf Stream is slowing down faster than ever, scientists say
Government gives £250,000 to Independent appeal

Government gives £250,000 to Independent appeal

Donation brings total raised by Homeless Veterans campaign to at least £1.25m
Oh dear, the most borrowed book at Bank of England library doesn't inspire confidence

The most borrowed book at Bank of England library? Oh dear

The book's fifth edition is used for Edexcel exams
Cowslips vs honeysuckle: The hunt for the UK’s favourite wildflower

Cowslips vs honeysuckle

It's the hunt for UK’s favourite wildflower
Child abuse scandal: Did a botched blackmail attempt by South African intelligence help Cyril Smith escape justice?

Did a botched blackmail attempt help Cyril Smith escape justice?

A fresh twist reveals the Liberal MP was targeted by the notorious South African intelligence agency Boss